0      0

AM21-74: Deoxyribonucleic Acid (DNA) Reference Cell Lines and Sequences for Precision Medicine

‐ Oct 19, 2021 9:00pm

Expiration Date: Dec 31, 2023

Credits: None available.

We all like to have strong references, don't we? New DNA reference material is becoming available. Proficiency programs in immunohematology and red cell genotyping have relied on fresh red cells and DNA from blood donations for decades. This approach may change in the near future. Permanent cell lines have been established as a reliable, stable and strong source for DNA. The FDA offers this DNA as reference material. Such DNA samples are characterized at unprecedented detail, and their nucleotide sequences are being established at great lengths. The samples are ideal material for assay development and validation. Their reference DNA sequences are indispensable for precision medicine and diagnostics utilizing next generation sequencing. We describe the insight gleaned from such strong reference material for long-range nucleotide sequencing and the current progress in reference DNA availability.

Learning Objectives:

  • Summarize the reference nucleotide information available for application in next generation sequencing.
  • Recognize the utility of cell lines as stable and reliable source for reference DNA and strong reference nucleotide sequences at exceptional length.
  • Describe availability of reference DNA from cell lines for external quality assessment.




  • Maria Rios, PhD:
    Nothing to Disclose
  • Greg Denomme, PhD, FCSMLS:
    Employee, Speaker's Bureau: Grifols Laboratory Solutions
  • Willy Flegel, MD:
    Nothing to Disclose

By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.

Credits Available

AM21-74: Deoxyribonucleic Acid (DNA) Reference Cell Lines and Sequences for Precision Medicine Evaluation